WKP|Q59687413

Search

Select Field:

Select Index:

Search Terms:

Leader		00000nz a2200037n 45 0
001		WKP\|Q59687413 (VIAF cluster) (Authority/Source Record)
003		WKP
005		20241221010848.0
008		241221nneanz\|\|abbn n and d
035		‎‡a (WKP)Q59687413‏
024		‎‡a 0000-0002-4571-7721‏ ‎‡2 orcid‏
035		‎‡a (OCoLC)Q59687413‏
100	0	‎‡a David Jimenez‏ ‎‡c researcher ORCID ID = 0000-0002-4571-7721‏ ‎‡9 en‏
375		‎‡a 1‏ ‎‡2 iso5218‏
400	0	‎‡a David Jimenez‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670		‎‡a Author's Accuracy and Interobserver Reliability of the Simplified Pulmonary Embolism Severity Index Versus the Hestia Criteria for Patients With Pulmonary Embolism‏
670		‎‡a Author's Assembly 13: placing the pulmonary circulation in the heart of ERS‏
670		‎‡a Author's Atrial fibrillation in the course of pulmonary embolism: just a little smoke, or fuel to the fire?‏
670		‎‡a Author's Clinical characteristics and 3-month outcomes in cancer patients with incidental <i>versus</i> clinically-suspected and confirmed pulmonary embolism‏
670		‎‡a Author's Comparative clinical prognosis of massive and non-massive pulmonary embolism: a registry-based cohort study‏
670		‎‡a Author's Diclofenac for reversal of right ventricular dysfunction in acute normotensive pulmonary embolism: A pilot study.‏
670		‎‡a Author's Highlights from the ERS International Congress 2018: Assembly 13 - Pulmonary Vascular Diseases‏
670		‎‡a Author's Hospital volume and outcomes for acute pulmonary embolism: multinational population based cohort study‏
670		‎‡a Author's Impact of obstructive sleep apnea on cardiovascular outcomes in patients with acute symptomatic pulmonary embolism: Rationale and methodology for the POPE study‏
670		‎‡a Author's Implications of Abnormal Troponin Levels With Normal Right Ventricular Function in Normotensive Patients With Acute Pulmonary Embolism‏
670		‎‡a Author's Management appropriateness and outcomes of patients with acute pulmonary embolism‏
670		‎‡a Author's Meta-Analysis of Prevalence and Short-Term Prognosis of Hemodynamically Unstable Patients With Symptomatic Acute Pulmonary Embolism‏
670		‎‡a Author's Obstructive sleep apnoea and venous thromboembolism: pathophysiological links and clinical implications‏
670		‎‡a Author's Outpatient therapy for acute symptomatic pulmonary embolism diagnosed in the emergency department: Time to improve the evidence base.‏
670		‎‡a Author's Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study.‏
670		‎‡a Author's Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions‏
670		‎‡a Author's Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry‏
670		‎‡a Author's Sex differences in the characteristics and short-term prognosis of patients presenting with acute symptomatic pulmonary embolism‏
670		‎‡a Author's The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease‏
909		‎‡a (orcid) 0000000245717721‏ ‎‡9 1‏
919		‎‡a impactofobstructivesleepapneaoncardiovascularoutcomesinpatientswithacutesymptomaticpulmonaryembolismrationaleandmethodologyforthepopestudy‏ ‎‡A Impact of obstructive sleep apnea on cardiovascular outcomes in patients with acute symptomatic pulmonary embolism: Rationale and methodology for the POPE study‏ ‎‡9 1‏
919		‎‡a sexdifferencesinthecharacteristicsandshorttermprognosisofpatientspresentingwithacutesymptomaticpulmonaryembolism‏ ‎‡A Sex differences in the characteristics and short-term prognosis of patients presenting with acute symptomatic pulmonary embolism‏ ‎‡9 1‏
919		‎‡a implicationsofabnormaltroponinlevelswithnormalrightventricularfunctioninnormotensivepatientswithacutepulmonaryembolism‏ ‎‡A Implications of Abnormal Troponin Levels With Normal Right Ventricular Function in Normotensive Patients With Acute Pulmonary Embolism‏ ‎‡9 1‏
919		‎‡a rateanddurationofhospitalisationforacutepulmonaryembolismintherealworldclinicalpracticeofdifferentcountriesanalysisfromtherieteregistry‏ ‎‡A Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry‏ ‎‡9 1‏
919		‎‡a managementappropriatenessandoutcomesofpatientswithacutepulmonaryembolism‏ ‎‡A Management appropriateness and outcomes of patients with acute pulmonary embolism‏ ‎‡9 1‏
919		‎‡a pulmonaryembolismresponseteamspurposeevidenceforefficacyandfutureresearchdirections‏ ‎‡A Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions‏ ‎‡9 1‏
919		‎‡a prognosticimpactofcopeptininpulmonaryembolismamulticentrevalidationstudy‏ ‎‡A Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study.‏ ‎‡9 1‏
919		‎‡a outpatienttherapyforacutesymptomaticpulmonaryembolismdiagnosedintheemergencydepartmenttimetoimprovetheevidencebase‏ ‎‡A Outpatient therapy for acute symptomatic pulmonary embolism diagnosed in the emergency department: Time to improve the evidence base.‏ ‎‡9 1‏
919		‎‡a metaanalysisofprevalenceandshorttermprognosisofhemodynamicallyunstablepatientswithsymptomaticacutepulmonaryembolism‏ ‎‡A Meta-Analysis of Prevalence and Short-Term Prognosis of Hemodynamically Unstable Patients With Symptomatic Acute Pulmonary Embolism‏ ‎‡9 1‏
919		‎‡a obstructivesleepapnoeaandvenousthromboembolismpathophysiologicallinksandclinicalimplications‏ ‎‡A Obstructive sleep apnoea and venous thromboembolism: pathophysiological links and clinical implications‏ ‎‡9 1‏
919		‎‡a accuracyandinterobserverreliabilityofthesimplifiedpulmonaryembolismseverityindexversusthehestiacriteriaforpatientswithpulmonaryembolism‏ ‎‡A Accuracy and Interobserver Reliability of the Simplified Pulmonary Embolism Severity Index Versus the Hestia Criteria for Patients With Pulmonary Embolism‏ ‎‡9 1‏
919		‎‡a assembly13placingthepulmonarycirculationintheheartofers‏ ‎‡A Assembly 13: placing the pulmonary circulation in the heart of ERS‏ ‎‡9 1‏
919		‎‡a atrialfibrillationinthecourseofpulmonaryembolismjustalittlesmokeorfueltothefire‏ ‎‡A Atrial fibrillation in the course of pulmonary embolism: just a little smoke, or fuel to the fire?‏ ‎‡9 1‏
919		‎‡a clinicalcharacteristicsand3monthoutcomesincancerpatientswithincidental1versus1clinicallysuspectedandconfirmedpulmonaryembolism‏ ‎‡A Clinical characteristics and 3-month outcomes in cancer patients with incidental <i>versus</i> clinically-suspected and confirmed pulmonary embolism‏ ‎‡9 1‏
919		‎‡a comparativeclinicalprognosisofmassiveandnonmassivepulmonaryembolismaregistrybasedcohortstudy‏ ‎‡A Comparative clinical prognosis of massive and non-massive pulmonary embolism: a registry-based cohort study‏ ‎‡9 1‏
919		‎‡a diclofenacforreversalofrightventriculardysfunctioninacutenormotensivepulmonaryembolismapilotstudy‏ ‎‡A Diclofenac for reversal of right ventricular dysfunction in acute normotensive pulmonary embolism: A pilot study.‏ ‎‡9 1‏
919		‎‡a rationaledesignandmethodsofarandomizedcontrolledtrialtoevaluatetheefficacyandsafetyofanactivestrategyforthediagnosisandtreatmentofacutepulmonaryembolismduringexacerbationsofchronicobstructivepulmonarydisease‏ ‎‡A The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease‏ ‎‡9 1‏
919		‎‡a highlightsfromtheersinternationalcongress2018assembly13pulmonaryvasculardiseases‏ ‎‡A Highlights from the ERS International Congress 2018: Assembly 13 - Pulmonary Vascular Diseases‏ ‎‡9 1‏
919		‎‡a hospitalvolumeandoutcomesforacutepulmonaryembolismmultinationalpopulationbasedcohortstudy‏ ‎‡A Hospital volume and outcomes for acute pulmonary embolism: multinational population based cohort study‏ ‎‡9 1‏
946		‎‡a b‏ ‎‡9 1‏
996		‎‡2 ISNI\|0000000026660593‏
996		‎‡2 DNB\|14021366X‏
996		‎‡2 BNE\|XX898583‏
996		‎‡2 BNC\|981058511977106706‏
996		‎‡2 BNE\|XX5554941‏
996		‎‡2 SUDOC\|236533649‏
996		‎‡2 BNE\|XX5380633‏
996		‎‡2 SUDOC\|112381707‏
996		‎‡2 SUDOC\|272936987‏
996		‎‡2 W2Z\|1707991623113‏
996		‎‡2 ISNI\|0000000059254305‏
996		‎‡2 BNF\|14470778‏
996		‎‡2 BNF\|16705304‏
996		‎‡2 ISNI\|0000000049548748‏
996		‎‡2 BIBSYS\|2095943‏
996		‎‡2 LC\|no2022095092‏
996		‎‡2 ISNI\|0000000119959762‏
996		‎‡2 BNE\|XX4992647‏
996		‎‡2 ISNI\|0000000433440619‏
996		‎‡2 LC\|no2015158693‏
996		‎‡2 BNE\|XX1223884‏
996		‎‡2 ISNI\|0000000048543590‏
996		‎‡2 BNE\|XX1542384‏
996		‎‡2 ISNI\|0000000118237522‏
996		‎‡2 LC\|no2021103192‏
996		‎‡2 LC\|no2011011666‏
996		‎‡2 ISNI\|0000000042926830‏
996		‎‡2 BNE\|XX4426640‏
996		‎‡2 BNE\|XX846281‏
996		‎‡2 SUDOC\|249907747‏
996		‎‡2 ISNI\|0000000078242625‏
996		‎‡2 LC\|n 86038873‏
996		‎‡2 JPG\|500291057‏
996		‎‡2 BNC\|981058517398906706‏
996		‎‡2 LC\|no2013135817‏
996		‎‡2 ISNI\|0000000116797462‏
996		‎‡2 BIBSYS\|90723985‏
996		‎‡2 RERO\|A009690246‏
996		‎‡2 BNE\|XX1538258‏
996		‎‡2 ISNI\|0000000024257397‏
996		‎‡2 BNE\|XX1416029‏
996		‎‡2 SUDOC\|259783579‏
996		‎‡2 ISNI\|0000000059307542‏
996		‎‡2 BNF\|17140971‏
996		‎‡2 ISNI\|0000000495887854‏
996		‎‡2 ISNI\|0000000131774795‏
996		‎‡2 LC\|ns2018000298‏
996		‎‡2 LC\|no2006053973‏
996		‎‡2 SUDOC\|262322943‏
996		‎‡2 LC\|no2010108963‏
996		‎‡2 DNB\|1140461249‏
996		‎‡2 LC\|ns2015001687‏
996		‎‡2 BNE\|XX4705019‏
996		‎‡2 ISNI\|0000000454459271‏
996		‎‡2 DNB\|1032971266‏
996		‎‡2 BNF\|16512733‏
996		‎‡2 ISNI\|0000000442462377‏
996		‎‡2 BNC\|981058510530006706‏
996		‎‡2 BNE\|XX5729948‏
996		‎‡2 DNB\|1151161942‏
996		‎‡2 DNB\|137584024‏
996		‎‡2 SUDOC\|060347449‏
996		‎‡2 BNC\|981058609184606706‏
996		‎‡2 LC\|no 93003482‏
996		‎‡2 BNE\|XX5578507‏
996		‎‡2 BNE\|XX843883‏
996		‎‡2 BNC\|981058479364806706‏
996		‎‡2 BNE\|XX1343375‏
996		‎‡2 NTA\|418046956‏
996		‎‡2 BNE\|XX1098084‏
996		‎‡2 PLWABN\|9810688020305606‏
996		‎‡2 LC\|no2020073414‏
996		‎‡2 BNC\|981058520273706706‏
996		‎‡2 LC\|n 2017005200‏
996		‎‡2 LC\|n 98000347‏
996		‎‡2 ISNI\|0000000063014558‏
996		‎‡2 BNE\|XX4662364‏
996		‎‡2 PLWABN\|9810556260005606‏
996		‎‡2 ISNI\|0000000043175012‏
996		‎‡2 NTA\|418973458‏
996		‎‡2 LC\|n 85175962‏
996		‎‡2 LC\|no 92028528‏
996		‎‡2 ISNI\|0000000088248449‏
996		‎‡2 LC\|no2019133388‏
996		‎‡2 RERO\|A006340424‏
996		‎‡2 NDL\|001358385‏
996		‎‡2 ISNI\|0000000039506093‏
996		‎‡2 BNC\|981058509161206706‏
996		‎‡2 BNF\|17168774‏
996		‎‡2 DNB\|1262346878‏
996		‎‡2 BNC\|981058610727206706‏
996		‎‡2 BNE\|XX5103983‏
996		‎‡2 BNE\|XX4665898‏
996		‎‡2 SUDOC\|195591623‏
996		‎‡2 LC\|n 2019024696‏
996		‎‡2 NKC\|xx0213581‏
996		‎‡2 BNE\|XX5556749‏
996		‎‡2 BIBSYS\|1707991623113‏
996		‎‡2 BNE\|XX6222650‏
996		‎‡2 BNE\|XX1706476‏
996		‎‡2 BIBSYS\|1675320984186‏
996		‎‡2 NTA\|417573464‏
996		‎‡2 W2Z\|1675320984186‏
996		‎‡2 LC\|no2009111050‏
996		‎‡2 BNC\|981058517229706706‏
996		‎‡2 CAOONL\|ncf13676454‏
996		‎‡2 LC\|no2022111168‏
996		‎‡2 RERO\|A003425806‏
996		‎‡2 LC\|no 99082993‏
996		‎‡2 ISNI\|0000000078734793‏
996		‎‡2 LC\|no2004084815‏
996		‎‡2 LC\|n 2008031156‏
996		‎‡2 LC\|ns2021000445‏
996		‎‡2 LC\|ns2023003209‏
996		‎‡2 BNC\|981058580316806706‏
996		‎‡2 DNB\|1057066729‏
996		‎‡2 DNB\|1116746506‏
996		‎‡2 LC\|no2007002426‏
996		‎‡2 RERO\|A024752547‏
996		‎‡2 LC\|n 93023034‏
996		‎‡2 SUDOC\|191591572‏
996		‎‡2 LC\|n 82275257‏
996		‎‡2 J9U\|987011416119105171‏
996		‎‡2 BNE\|XX5581016‏
996		‎‡2 SUDOC\|250715880‏
996		‎‡2 BNC\|981058508151906706‏
996		‎‡2 SUDOC\|149128991‏
996		‎‡2 LC\|no2006041287‏
996		‎‡2 ISNI\|0000000460598585‏
996		‎‡2 NTA\|148390196‏
996		‎‡2 ISNI\|0000000025399020‏
996		‎‡2 LC\|no2011044525‏
996		‎‡2 SUDOC\|179904949‏
996		‎‡2 DNB\|1154395723‏
996		‎‡2 SUDOC\|280965370‏
996		‎‡2 SUDOC\|26087471X‏
996		‎‡2 BNE\|XX4429127‏
996		‎‡2 RERO\|A027494208‏
996		‎‡2 ISNI\|0000000383177639‏
996		‎‡2 BNC\|981058609388506706‏
996		‎‡2 LC\|ns2018003206‏
996		‎‡2 LC\|n 2023008182‏
996		‎‡2 BNF\|16974969‏
996		‎‡2 BNE\|XX1141425‏
996		‎‡2 BNF\|17034222‏
996		‎‡2 LIH\|LNB:C_r_Q_y_;=CP‏
996		‎‡2 NSK\|000676087‏
996		‎‡2 BNCHL\|10000000000000000260533‏
996		‎‡2 LC\|n 2014047278‏
996		‎‡2 LC\|nr 99005547‏
996		‎‡2 NTA\|431870128‏
996		‎‡2 ISNI\|0000000038019314‏
996		‎‡2 BNC\|981058611801806706‏
996		‎‡2 BNC\|981060026162606706‏
996		‎‡2 DNB\|1074891872‏
996		‎‡2 ISNI\|0000000410242871‏
996		‎‡2 SUDOC\|132081210‏
996		‎‡2 DNB\|1057052256‏
996		‎‡2 LC\|n 80120421‏
996		‎‡2 ISNI\|000000006013479X‏
996		‎‡2 ISNI\|000000004489131X‏
996		‎‡2 DNB\|1252627092‏
996		‎‡2 DNB\|131806874‏
996		‎‡2 BNE\|XX1053649‏
996		‎‡2 LC\|no2021059836‏
996		‎‡2 BNE\|XX4994475‏
996		‎‡2 BNC\|981058512965406706‏
996		‎‡2 PLWABN\|9813658262005606‏
996		‎‡2 PTBNP\|1756667‏
996		‎‡2 DNB\|1057612995‏
996		‎‡2 BNC\|981058613182606706‏
996		‎‡2 SUDOC\|077328825‏
996		‎‡2 LC\|ns2022000677‏
996		‎‡2 BNE\|XX5266864‏
996		‎‡2 BNF\|17775404‏
996		‎‡2 PLWABN\|9811309963405606‏
996		‎‡2 LC\|no2009071750‏
996		‎‡2 LC\|no2016038495‏
996		‎‡2 ISNI\|0000000112188483‏
996		‎‡2 LC\|no2013072304‏
996		‎‡2 LC\|no2023119862‏
996		‎‡2 BNE\|XX4853810‏
996		‎‡2 BNC\|981058610343506706‏
996		‎‡2 BNF\|15053179‏
996		‎‡2 LC\|ns2011001793‏
996		‎‡2 SUDOC\|23461773X‏
996		‎‡2 BNE\|XX5051278‏
996		‎‡2 SUDOC\|176531327‏
996		‎‡2 LC\|n 2012061885‏
996		‎‡2 DNB\|1245892614‏
996		‎‡2 PTBNP\|1908194‏
996		‎‡2 LC\|nr2001017719‏
996		‎‡2 NKC\|jo2018991401‏
996		‎‡2 BNC\|981058517425106706‏
996		‎‡2 JPG\|500284598‏
996		‎‡2 BNE\|XX5595526‏
996		‎‡2 NUKAT\|nx2023000624‏
996		‎‡2 ISNI\|0000000039814811‏
996		‎‡2 PTBNP\|219785‏
996		‎‡2 ISNI\|0000000371894067‏
996		‎‡2 DNB\|116510069X‏
996		‎‡2 BNCHL\|10000000000000000099189‏
996		‎‡2 ISNI\|0000000420589430‏
996		‎‡2 DNB\|134774515‏
996		‎‡2 PTBNP\|569563‏
996		‎‡2 BNC\|981058520516106706‏
996		‎‡2 BNE\|XX5433424‏
996		‎‡2 BNC\|981058609963106706‏
996		‎‡2 BNE\|XX1537480‏
996		‎‡2 BNE\|XX1079093‏
997		‎‡a 0 0 lived 0 0‏ ‎‡9 1‏

VIAF

Virtual International Authority File

Search